Akzo Nobel (AKZA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
9 May, 2026Opening remarks and agenda
Meeting opened by the Supervisory Board Chair, with all board and executive members present and voting procedures explained.
Shareholders could participate in person or virtually, with questions allowed via microphone or chat.
The agenda and meeting notice were published in advance, confirming the meeting's legal validity.
Financial performance review
Efficiency programs delivered EUR 200 million in savings, boosting profitability and expanding Adjusted EBITDA margin to 14.2%.
Free cash flow exceeded EUR 600 million, up 65% year-over-year, with net debt reduced below EUR 3 billion.
Sale of the India business generated EUR 900 million at a 25x EBITDA multiple; portfolio review in Southeast Asia ongoing.
Sustainability progress included a 47% reduction in operational emissions and 69% renewable electricity usage.
Return on investment improved from 9.8% to 13.5%; midterm targets set for 2027 include 16%-19% ROI and 16% EBITDA margin.
Board and executive committee updates
No salary increases for CEO and CFO in 2025; performance-based incentives awarded based on above-target results.
Remuneration policy and outcomes detailed, with focus on efficiency, industrial excellence, and portfolio management.
CFO Maarten de Vries reappointed with a one-time EUR 750,000 retention payment due to the merger's critical phase.
Latest events from Akzo Nobel
- Q2 2026 delivered margin expansion and EBITDA growth, with Axalta merger and risks in focus.AKZA
Q2 202628 Jul 2026 - All-stock merger forms a $17B coatings leader, targeting $600M synergies and global scale.AKZA
M&A Announcement9 Jul 2026 - Q3 EBITDA margin rose to 15.1%, free cash flow improved, and a €300m legal provision was booked.AKZA
Q3 20258 Jul 2026 - Adjusted EBITDA margin rose to 14.5% despite revenue decline; Deco and Asia drove growth.AKZA
Q1 202623 Apr 2026 - Flat sales, margin gains, and India divestment set stage for Axalta merger and future growth.AKZA
Q4 20253 Feb 2026 - Q2 2024 saw 2% organic sales growth, stable EBITDA, and strong Performance Coatings results.AKZA
Q2 20243 Feb 2026 - Q3 2024 delivered 1% organic growth, margin gains, and ongoing cost actions amid FX headwinds.AKZA
Q3 202419 Jan 2026 - Adjusted EBITDA rose 3% to €1.5 billion, with 2025 guidance set above €1.55 billion.AKZA
Q4 20249 Jan 2026 - Q1 EBITDA held at €357m as cost actions offset lower volumes; 2025 guidance reaffirmed.AKZA
Q1 202521 Dec 2025